When the party's over

Article Abstract:

The failure of cholesterol-lowering drug torcetrapib associated with high death rates in a late-clinical trial and present cholesterol drug Lipitor bringing the company more than $12 billion in annual revenues losing patent protection in 2011 leaves Pfizer in search of new corporate strategy to deal with the post-blockbuster age. Pfizer was one of the few remaining companies that appeared to be able to manage the mega-blockbuster drugs and presently has 242 products at various stages in its pipeline.

Sales, profits & dividends, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Product discontinued, Lipotropics & Cholesterol Reducers, United States, Pharmaceutical industry, Complications and side effects, Company sales and earnings, Pfizer Inc., Company earnings/profit, PFE, Anticholesteremic agents, Product discontinuation

---

Regulator under siege

Article Abstract:

The Maryland-based, U.S. Food and Drug Administration (FDA) agency, responsible for the supervising the majority of the aspects of food and drug safety , is under investigation after it approved a dog food which caused death of several pets.

Legal issues & crime, Product information, Management dynamics, Dog and Cat Food Manufacturing, Maryland, Dog and cat food, Dog Food, Management, Company legal issue, Investigations, Testing, Company business management, United States. Food and Drug Administration, Pet food

---

Similar abstracts:

• Abstracts: Blair's failure. English grants under review. London's disastrous drug trial has effects for serious side research
• Abstracts: Getting the right mix. Scientists attack Bush over intelligent design. Special report
• Abstracts: The carbon game. Role of state climatologist comes under scrutiny. Caught between shores
• Abstracts: Them and us no longer. Revamp for NIH grants. Solid foundations: In praise of those physicists who are unobtrusively revolutionizing everyday life
• Abstracts: Melting in the earth's deep upper mantle caused by carbon dioxide. Phenotypic consequences of 1,000 generations of selection at elevated CO2 in a green alga

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.